Lataa...
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
The retained functionality of the sodium iodide symporter (NIS) expressed in differentiated thyroid cancer (DTC) cells allows the further utilization of post-surgical radioactive iodine (RAI) therapy, which is an effective treatment for reducing the risk of recurrence, and even the mortality, of DTC...
Tallennettuna:
| Julkaisussa: | Endocrinol Metab (Seoul) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Korean Endocrine Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769341/ https://ncbi.nlm.nih.gov/pubmed/31565873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2019.34.3.215 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|